Scientists and clinicians are tracking steady gains in human lifespan and debating how far we can push longevity, from rising life expectancy to new biological clocks and bold predictions that humans might one day live much longer than today.
Global data show people are living longer compared with past generations, and the United States recently reached a new high in average lifespan. Life expectancy climbed to 79 years in 2024, a jump many experts link to fewer deaths from COVID, reduced unintentional injuries like overdoses, and improvements in heart disease and cancer care. Those shifts are nudging conversations about what comes next for human aging.
One prominent voice in that conversation is Dr. Steve Horvath, a geneticist working at Altos Labs Cambridge Institute of Science, who has suggested humans could eventually reach much greater ages. He has been quoted saying, “150 is a very fashionable number now,” and added, “I have no doubt it will happen. No question.” He did not provide a timeline, but his prediction rests on rapid advances in biological aging research.
Horvath built his reputation by developing tools to quantify aging at the molecular level, and he began with an influential “aging clock” in the early 2010s. The original clock incorporated saliva data and proved useful across tissues, including blood, skin and other organs, which helped researchers move beyond rough chronological age into real measurements of biological wear. Those tools have evolved into several models that studies show can predict mortality risk and reveal how fast different bodies are aging.
He has described his motivation plainly: “I felt that it was important to develop [an aging] clock to advance scientific inquiry in the field of longevity,” and he added, “I felt we needed exact measurements of aging before we could really study it, and then hopefully one day find interventions that can reverse aging.” That focus on precise metrics is central to testing whether treatments actually change the biology of aging rather than just postponing symptoms.
Horvath is careful about extremes, noting he no longer expects lifespans like 1,000 years, but he remains upbeat about sizable shifts. He asked rhetorically, “Imagine we have 100 more years of biomedical innovations — what will that do for health?” and followed with, “Of course, we would expect major breakthroughs.” He also put those hopes in context: “So, in an abstract sense … if we can avoid wars and pandemics, I think our species at some point will find ways to extend lifespan drastically.”
Outside of academic labs, clinicians and industry figures are watching these developments closely and weighing what they mean for patients and public health. Dr. Eve Henry, chief medical officer at a personalized health platform, called Horvath’s view “not an impossible take,” and described the overall research mood as “very optimistic.” Her perspective emphasizes testing and measurement as the practical next steps for translating promising signals into real treatments.
She emphasized that the crucial first move is better measurement: “The research is correct. The first step in this process is to accurately measure biological age and the speed of aging in real time,” and she explained, “This will allow us to test interventions for improved longevity quickly, rather than set up aging experiments that would take decades to complete.” In her view, the ability to measure aging in real time gives researchers new leverage to sort good ideas from bad ones much faster. “In science, once you can truly measure something, it gives you new power to study it.”
Henry also warned that turning measurement into meaningful lifespan gains will require dramatic interventions that reset core physiology, not just incremental fixes. “While I haven’t seen that intervention yet, I’m excited to be alive in an era when this kind of research is possible,” she said, underscoring a mix of cautious hope and scientific realism. The gap between a long life and a long, high-quality life remains the central challenge.
How those extra years might play out for individuals will depend heavily on whether independence and function can be preserved alongside longevity tools and care. “There’s a key difference in living 50 to 70 years longer if independence can be sustained with the longevity tools and care available, compared to the idea of even living 10 years beyond the average life span today, which requires extensive health and community assistance,” she said. Henry closed with a reminder of uncertainty: “This research is certainly promising, but the reality is that only time can tell what the future of human lifespan could really look like.”
